Recursion Pharmaceutical is reinventing drug discovery through artificial intelligence (AI) with a solution that rivals,
and exceeds, the processing platforms used by the largest pharmaceutical companies. The six-year old startup,
based in Salt Lake City, executes about 350,000 experiments weekly and screens thousands of compounds against
hundreds of disease models—at a fraction of the cost and time of traditional drug discovery methods.

According to Kris Howard, Principal Systems Engineer at Recursion Pharmaceutical, AI and machine learning play
an important role in understanding human biology. “We leverage machine learning to ask complex questions about
biology, and get faster answers,” he explains. “Recursion combines dry and wet lab capabilities to confidently
generate actionable insights on human biology for rapid discovery of novel treatments.”